Duke University School of Medicine received $455 million in funding from the National Institutes of Health (NIH) in 2024, according to the Blue Ridge Institute for Medical Research. The federal funding advances medical science and improves patient care.
In the new rankings, Duke School of Medicine placed 13th among the nation’s medical schools based on grants awarded during the federal fiscal year ending September 30, 2024. Duke University received $580 million in NIH grants and contracts, ranking 11th in NIH support among research institutions.
Behind the numbers is a broader story of scientists tackling pressing questions about aging, disease, and mechanics of human health, all driven by a shared pursuit of discovery.
“NIH funding is the backbone of transformative scientific discovery,” said Mary E. Klotman, MD, executive vice president for health affairs at Duke University and dean of the School of Medicine. “These investments empower our researchers to push the boundaries of medicine. However, research isn’t just about bold ideas — it requires laboratories, data infrastructure, and skilled teams who bring science to life. NIH support of these essential foundations has been critical in turning these discoveries into real and lasting improvements in human health.”
In 2024, eight clinical and basic science departments at Duke School of Medicine ranked in the nation’s top 10:
Clinical Departments
- Surgery 1st
- Orthopedics 2nd
- Anesthesiology 4th
- Internal Medicine 8th
- Neurosurgery 9th
- Ophthalmology 9th
Basic Science Departments
- Biostatistics and Bioinformatics 2nd
- Genetics 9th
- Pharmacology 7th
As the largest public funder of biomedical research globally, the NIH plays a crucial role in advancing health for all. By investing in institutions like Duke, the NIH fuels scientific research and translates knowledge into tangible improvements for patients.